Bunge Global enters its May 20 earnings release with the Street firmly in its corner — but the stock trading below the consensus target raises questions about what the quarter needs to deliver.
The analyst picture is one-directional. Barclays raised its price target to $150 on April 30, maintaining Overweight, after previously lifting from $135 to $145 in early April. JPMorgan and Morgan Stanley both raised targets in March. Across the past several months, every notable move has been an upgrade or a target increase — no firm has cut or moved to the sidelines. The mean target of $142 implies roughly 16% upside from the current price of $122.45, a gap that widened as the stock slipped 2% on the week.
The bull case rests on improving crush margins, biofuel policy clarity lifting demand, and the Viterra integration adding scale to the global grains business. Bears point to deteriorating Agribusiness EBIT, weaker processing results, and year-over-year declines across Refined & Specialty Oils and Milling — a pattern that suggests the macro tailwinds have yet to fully offset segment-level pressure. EPS momentum is the most interesting tension: the 30-day and 90-day momentum scores rank in the 96th and 90th percentiles respectively, suggesting forward estimates have been climbing sharply even as the valuation has compressed. The P/E multiple has fallen roughly 1.3 points over the past month to 12.4x — cheap relative to the improving estimates story, but consistent with a market waiting for hard evidence.
Short interest paints an undemanding picture. At 2.7% of the free float, it has edged up about 1.2% on the week but remains well below levels seen in mid-April. Borrowing costs are inexpensive at 0.49%, and the lending market is far from tight. Options positioning is also relaxed — the put/call ratio of 0.28 is only modestly above its 20-day average, close to the 52-week low end of the range. Neither the borrow market nor the options market signals meaningful defensive positioning ahead of the print.
Insider activity adds a note of caution. On March 13, the CEO, CFO, Chief Legal Officer, and several divisional presidents all sold shares simultaneously, with the CEO alone disposing of roughly $4.9 million worth at $125.63. Net insider selling over the past 90 days reached approximately $8.3 million. Cluster selling of this kind at the executive level is worth noting, even if the timing — two months before the print — limits its direct read-through.
The May 20 report is therefore less about whether the bull thesis is intact and more about whether segment-level results have finally begun to reflect the improving forward estimates that analysts have been pencilling in.
See the live data behind this article on ORTEX.
Open BG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
